In the last trading session, 1.94 million shares of the Personalis Inc (NASDAQ:PSNL) were traded, and its beta was 1.88. Most recently the company’s share price was $6.68, and it changed around -$0.77 or -10.34% from the last close, which brings the market valuation of the company to $590.01M. PSNL currently trades at a discount to its 52-week high of $7.79, offering almost -16.62% off that amount. The share price’s 52-week low was $1.20, which indicates that the current value has risen by an impressive 82.04% since then. We note from Personalis Inc’s average daily trading volume that its 10-day average is 2.29 million shares, with the 3-month average coming to 1.02 million.
Personalis Inc stock received a consensus recommendation rating of Buy, based on a mean score of 1.25. If we narrow it down even further, the data shows that 0 out of 7 analysts rate the stock as a Sell; another 2 rate it as Overweight. Among the rest, 1 recommended PSNL as a Hold, whereas 4 deemed it a Buy, and 0 rated it as Underweight. Personalis Inc is expected to report earnings per share of -0.24 for the current quarter.
Personalis Inc (NASDAQ:PSNL) trade information
Instantly PSNL has showed a red trend with a performance of -10.34% at the end of last trading. The performance over the last five days has remained in the green territory. The rise to weekly highs of 7.79 on recent trading dayincreased the stock’s daily price by 14.25%. The company’s shares are currently up 456.67% year-to-date, but still up 1.52% over the last five days. On the other hand, Personalis Inc (NASDAQ:PSNL) is 29.71% up in the 30-day period. We can see from the shorts that 3.86 million shares have been sold at a short interest cover period of 5.55 day(s).
The consensus price target as assigned by Wall Street analysts is $7.5, which translates to bulls needing to increase their stock price by 10.93% from its current value. Analyst projections state that PSNL is forecast to be at a low of $4 and a high of $13.
Personalis Inc (PSNL) estimates and forecasts
The year-over-year growth rate is expected to be -1.46%, down from the previous year.
Consensus estimates provided by 7 financial analysts predict the company will bring in an average of 20.12M in revenue for the current quarter. 7 analysts expect Personalis Inc to make 18.87M in revenue for the current ending quarter. The company’s sales for the same quarters a year ago were 22.58M and 25.71M respectively. Analysts predict that the company’s current quarter sales will drop, forecast at -10.91%. Forecasts for the next quarter put sales growth at -26.58%.
Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -11.31%. Personalis Inc earnings are expected to increase by 30.93% in 2025, but the outlook is positive 16.56% per year for the next five years.
PSNL Dividends
Personalis Inc’s next quarterly earnings report is expected to be released on 2025-May-06.
Personalis Inc (NASDAQ:PSNL)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 31.49% of Personalis Inc shares, and 46.11% of them are in the hands of institutional investors. The stock currently has a share float of 67.30%. Personalis Inc stock is held by 143.0 institutions, with ARK INVESTMENT MANAGEMENT LLC being the largest institutional investor. By 2024-06-30, it held 12.1422% of the shares, which is about 6.36 million shares worth $7.44 million.
BLACKROCK INC., with 6.2833% or 3.29 million shares worth $3.85 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
ARK ETF Trust-ARK Genomic Revolution ETF and abrdn Life Sciences Investors were the top two Mutual Funds as of May 31, 2025 . The former held 6.85 shares worth $45.73 million, making up 7.75% of all outstanding shares. On the other hand, abrdn Life Sciences Investors held roughly 873.87 shares worth around $5.84 million, which represents about 0.99% of the total shares outstanding.
